Endocrinology Medical News about Thyroid Neoplasms

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium
European Journal of Nuclear Medicine & Molecular Imaging, 09/23/09

Barbaro D et al. – RhTSH is highly effective for post–surgical thyroid remnant ablation in low–risk cancer patients using the low 30–mCi dose protocol combined with the short 4–day withdrawal of L–T4. Moreover, in these patients the pre–treatment with furosemide seems to play an important role to further improve the outcome of ablation by reducing the iodine pool.

<< Previous
Differential Expression and Activity of 11 beta-Hydroxysteroid...

Next >>
Instruments to tailor care of people with type 2 diabetes